National Survey on Hypertension at Hospital
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00695266
- Lead Sponsor
- AstraZeneca
- Brief Summary
To evaluate (with sufficient accuracy) the profile(demographic and clinical characteristics, health care management) of hypertensive patients seen in hospital out patient's department by a cardiologist or a nephrologists.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 655
Inclusion Criteria
- Known hypertension
- agree to take part in this study
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Demographic, clinical and health care characteristics Once
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What demographic and clinical characteristics are associated with hypertension management in hospital outpatient settings according to NCT00695266?
How does AstraZeneca's observational study on hypertensive patients contribute to understanding molecular mechanisms of antihypertensive drug targets?
What biomarkers correlate with effective healthcare management of hypertension in NCT00695266 outpatient cohort?
Are there comparative insights on adverse event profiles between AstraZeneca's hypertension management strategies and standard-of-care approaches in observational studies?
What therapeutic compounds or combination therapies are being explored for hypertension treatment in relation to the findings of NCT00695266?
Trial Locations
- Locations (1)
Research Site
🇫🇷Villeneuve St Georges Cedex, France
Research Site🇫🇷Villeneuve St Georges Cedex, France